Project Grant HT94252410977
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$730K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
Cedars-Sinai Medical Center was awarded a $1.9 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to support research on novel DZ-artemisinin for treatment of pancreatic cancer. The three-year award will fund preclinical research from August 2022 to August 2025 to investigate medical solutions for pancreatic cancer on the battlefield and for the American public through innovative biomedical research....
The Department of the Army Medical Command awarded Cedars-Sinai Medical Center a $601,684 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on Novel DZ-Artemisinin for Treatment of Pancreatic Cancer. The three-year award beginning August 15, 2022 will fund the development of an innovative therapy using DZ-Artemisinin derivatives to treat pancreatic cancer at Cedars-Sinai's facilities located in West Hollywood, California. The Military...
The Defense Health Agency awarded Cedars-Sinai Medical Center a $2,674,057 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective June 1, 2025 through May 31, 2029, will support advanced biomedical research to identify pathways of progression from acute pancreatitis to recurring acute pancreatitis and chronic pancreatitis. As a leading academic medical research center, Cedars-Sinai will leverage its expertise in translational research,...
The federal Project Grant award of $598,130.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research conducted by Cedars-Sinai Medical Center to investigate the determinants of lung cancer-associated cachexia. The research aims to transform healthcare for military service members and the broader public by advancing innovative and impactful biomedical research. The award, effective from February 15, 2025 to February 14, 2027, will...
This $4,089,970 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Cedars-Sinai Medical Center to investigate spatial reprogramming of tumor immune microenvironments through preoperative radiotherapy and immune checkpoint inhibition in HER2 negative breast cancer. The award will fund basic, translational, and clinical research over 4 years from September 2023 to August 2027 to develop new treatments,...
This Project Grant award of $1,252,479.00 from the Defense Health Agency supports Cedars-Sinai Medical Center's biomedical research to re-engineer the intratumoral myeloid-macrophage compartment and enhance the response to radiation and immunotherapy in triple-negative breast cancer. The award falls under the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for Service Members and the public through innovative and impactful research....
This Project Grant award from the Department of Defense's Defense Health Agency provides $1,195,956.00 to Cedars-Sinai Medical Center to conduct research on "Metabolic Vulnerabilities of MDSCs in the Melanoma Tumor Microenvironment". The grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to address military health needs, with a focus on cancer, neurological disorders, and other conditions affecting service...
This Project Grant award of $6,150,467, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a research project at Cedars-Sinai Medical Center to investigate the use of the drug simvastatin to improve patient-reported outcomes in individuals with chronic pancreatitis. The award has a period of performance from September 30, 2023 to September 29, 2027. As a leading academic medical center, Cedars-Sinai has an extensive track...
This $1,251,673.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center on August 1, 2023. The grant will fund research aimed at re-engineering the intratumoral myeloid-macrophage compartment to enhance the response to radiation and immunotherapy in triple-negative breast cancer. The three-year project will be performed at Cedars-Sinai's facilities in West Hollywood, CA. As a leading...
The federal Project Grant award, with ID HT94252510139, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $2,685,519.00 award to Cedars-Sinai Medical Center in West Hollywood, CA is funding research to define human correlates of super-evasive disseminated tumor cells, assess their pathological relevance, and investigate methods to eradicate them. This 4-year award, commencing on July 1, 2025, supports advanced biomedical...